Sherry Crowe

Title: Sherry Crowe: Innovator in Anthrax Research

Introduction

Sherry Crowe is a notable inventor based in Midwest City, Oklahoma. She has made significant contributions to the field of immunology, particularly in the development of compositions and methods for preventing anthrax infections. Her work is crucial in enhancing clinical outcomes for those affected by this serious disease.

Latest Patents

Sherry Crowe holds a patent for "Anthrax compositions and methods of use and production." This patent describes compositions and methods that effectively elicit an immune response to prevent or reduce infection caused by anthrax. The compositions include naturally occurring or synthetic proteins, peptides, or protein fragments that contain active portions of antigenic epitopes associated with anthrax toxin proteins. These compositions may be combined with a pharmaceutically acceptable carrier. The preferred antigenic epitopes correspond to immunogenic regions of protective antigen, lethal factor, or edema factor, either individually or in combination. Additionally, the patent outlines methods and compositions containing antibodies aimed at reducing the effects of anthrax toxins.

Career Highlights

Sherry Crowe is affiliated with the Oklahoma Medical Research Foundation, where she conducts her research. Her work has been instrumental in advancing the understanding of anthrax and developing effective treatments.

Collaborations

Sherry has collaborated with notable colleagues, including Judith Ann James and Darise Farris, to further her research efforts and enhance the impact of her work.

Conclusion

Sherry Crowe's innovative contributions to anthrax research highlight her dedication to improving public health. Her patent and ongoing work at the Oklahoma Medical Research Foundation underscore her role as a leading inventor in this critical field.